Verrica Pharmaceuticals (STU:1NE0) Float Percentage Of Total Shares Outstanding: 51.42% (As of Jul. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:1NE0 Verrica Pharmaceuticals Inc STU:1NE0
49 GF Score
Price €4.71
GF Value €12.20
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is Verrica Pharmaceuticals Float Percentage Of Total Shares Outstanding?

Verrica Pharmaceuticals STU:1NE0 -2.08% 49 Float Percentage Of Total Shares Outstanding is 51.42% as of Jul. 22, 2026. GuruFocus rates STU:1NE0 with a GF Score™ of 49/100 and a GF Value™ of €12.20 (Possible Value Trap). The stock has 2 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Verrica Pharmaceuticals's float shares is 8.83 Mil. Verrica Pharmaceuticals's total shares outstanding is 17.18 Mil. Verrica Pharmaceuticals's float percentage of total shares outstanding is 51.42%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Verrica Pharmaceuticals's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Verrica Pharmaceuticals's Institutional Ownership is 2.95%.

STU:1NE0
49GF Score
Verrica Pharmaceuticals Inc STU:1NE0
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Verrica Pharmaceuticals Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Verrica Pharmaceuticals's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=8.83/17.18
=51.42%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 51.42% mean?
Verrica Pharmaceuticals (STU:1NE0) has a Float Percentage Of Total Shares Outstanding of 51.42% as of Jul. 22, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Verrica Pharmaceuticals and its competitors.
Is Verrica Pharmaceuticals' Float Percentage Of Total Shares Outstanding too high?
Verrica Pharmaceuticals' current Float Percentage Of Total Shares Outstanding is 51.42%. Overall, Verrica Pharmaceuticals has a GF Score™ of 49/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Verrica Pharmaceuticals' Float Percentage Of Total Shares Outstanding compare to ENGN and PEPG?
Verrica Pharmaceuticals' Float Percentage Of Total Shares Outstanding of 51.42% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Verrica Pharmaceuticals and its competitors. Verrica Pharmaceuticals's current Float Percentage Of Total Shares Outstanding is 51.42%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Verrica Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Verrica Pharmaceuticals (STU:1NE0) is currently considered Possible Value Trap. The stock's GF Value™ is €12.20, compared to a current price of €4.71 — trading 61.4% below its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 51.42%. Verrica Pharmaceuticals' overall GF Score™ is 49/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Verrica Pharmaceuticals (STU:1NE0), the current Float Percentage Of Total Shares Outstanding is 51.42% as of Jul. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Verrica Pharmaceuticals (STU:1NE0) Overvalued in 2026?

Based on GuruFocus' analysis, Verrica Pharmaceuticals stock appears to be undervalued. The current stock price of €4.71 is trading 61.4% below its estimated GF Value™ of €12.20. GuruFocus considers Verrica Pharmaceuticals to be Possible Value Trap.

Key valuation signals for STU:1NE0:

  • Float Percentage Of Total Shares Outstanding: 51.42%
  • GF Value™: €12.20 vs. price of €4.71 (61.4% below fair value)
  • GF Score™: 49/100 with 2 warning signs

No single metric tells the full story. See the STU:1NE0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Verrica Pharmaceuticals Business Description

Other Exchanges VRCA:USA1NE0:Germany
Address 44 West Gay Street, Suite 400, West Chester, PA, USA, 19380
Verrica Pharmaceuticals Inc is a therapeutics company developing and commercializing medications for the treatment of dermatologic diseases, including skin cancers. Its commercial product and portfolio of product candidates are clinician administered therapies in areas of high unmet need. This product portfolio consists of one product with an approved indication for molluscum contagiosum, or molluscum, with the potential for several follow-on indications, as well as additional pipeline product candidates. Its commercial product, YCANTH (VP-102), for the treatment of molluscum in adult and pediatric patients two years of age and older. YCANTH (VP-102) is a proprietary drug-device combination that contains a GMP-controlled formulation of cantharidin.
49GF Score

Get the complete analysis for STU:1NE0

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.71
Price
€12.20
GF Value